Glenmede Trust’s MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% MSK.CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,659
Closed -$42K 2856
2015
Q1
$42K Hold
1,659
﹤0.01% 1736
2014
Q4
$41K Hold
1,659
﹤0.01% 1814
2014
Q3
$41K Hold
1,659
﹤0.01% 1763
2014
Q2
$41K Hold
1,659
﹤0.01% 1685
2014
Q1
$41K Hold
1,659
﹤0.01% 1704
2013
Q4
$38K Hold
1,659
﹤0.01% 1687
2013
Q3
$40K Hold
1,659
﹤0.01% 1645
2013
Q2
$40K Buy
+1,659
New +$41.8K ﹤0.01% 1576

Other funds holding MSK.CL

Glenmede Trust's MSK.CL Position: Q2 2015 in Review

Glenmede Trust sold out of MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% (MSK.CL) in Q2 2015, closing a stake of 1,659 shares — an estimated $42K sold.

Glenmede Trust first reported a position in MSK.CL in Q2 2013 and held it in 8 quarters. The position peaked at $42K in Q1 2015. 3 funds tracked by Wall St. Rank hold MSK.CL as of Q2 2015.

  • Glenmede Trust reported no remaining MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% position as of Q2 2015 after selling out during the quarter.
  • Glenmede Trust sold 1,659 MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% shares in Q2 2015, an estimated $42K.
  • Glenmede Trust first reported a position in MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% in Q2 2013 and held it in 8 quarters.
  • Glenmede Trust's MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% position peaked at $42K in Q1 2015.
  • 3 funds tracked by Wall St. Rank held MORGAN STANLEY CAP TRUST VIII GTD CAP SECURITIES 6.450% as of Q2 2015.

Based on Glenmede Trust's 13F filing for Q2 2015, filed 22 Jul 2015.